Form 4: Bruker CFO's Tax-Related Stock Transaction

Sentiment:

Insider Transaction Report 7 August 2025 4:15 PM

Bruker Corporation's CFO, Gerald N. Herman, reported a disposition of 577 common shares to cover tax obligations related to restricted stock unit vesting.

Summary

Gerald N. Herman, Executive Vice President and CFO of Bruker Corporation (BRKR), reported a transaction on August 5, 2025.
The transaction involved the disposition of 577 shares of Bruker Common Stock.
These shares were withheld by the company to satisfy tax withholding obligations.
The withholding was in connection with the vesting of restricted stock units previously granted to Mr. Herman.
The price per share for the withheld shares was $32.07.
Following this transaction, Mr. Herman beneficially owns 81,385 shares of Bruker Common Stock directly.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction itself is routine and expected for tax purposes related to executive compensation. The underlying event (vesting of RSUs) is positive for the executive, indicating earned compensation.

Positives

The transaction indicates the vesting of previously granted restricted stock units, which is a positive for the executive as it represents compensation earned.
The disposition was non-discretionary, solely for tax purposes, not a sale initiated by the executive.

Negatives

A reduction in direct share ownership, albeit for tax purposes, occurred.

Future Outlook

Industry Context

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Power of Attorney Grant	Gerald N. Herman granted a Power of Attorney to Michael A. Simone, Betsy A. Eberg, J. Brent Alldredge, and Thomas Bures to execute SEC Forms 3, 4, and 5 on his behalf.	February 2025	Streamlines compliance with Section 16(a) reporting requirements for the executive, ensuring timely and accurate filings.

Stakeholder Impact

Shareholders: Minimal direct impact as it's a routine, non-discretionary transaction for tax purposes related to executive compensation.
Employees: No direct impact beyond the executive involved.

Key Dates

Date	Description
February 2025	Power of Attorney executed by Gerald N. Herman.
08/05/2025	Date of the reported transaction (disposition of shares for tax withholding).
08/07/2025	Date the Form 4 was signed by the Attorney-in-Fact.

Recommendation

hold

This Form 4 filing details a routine, non-discretionary transaction by a company executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and do not typically indicate a change in the company's fundamental outlook or the executive's confidence. It provides no new information that would warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Bruker Corporation, BRKR, SEC Form 4, Insider Transaction, Gerald N. Herman, CFO, Stock Vesting, Tax Withholding, Restricted Stock Units, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.